Literature DB >> 23197084

Stereoselective synthesis and NMR characterization of C-24 epimeric pairs of 24-alkyl oxysterols.

Shoujiro Ogawa1, Hiroaki Kawamoto, Takashi Mitsuma, Hiroki Fujimori, Tatsuya Higashi, Takashi Iida.   

Abstract

Two pairs of C-24 epimeric (24R)-/(24S)-24-hydroxy-24-methyl-5α-cholestan-3β-yl acetates and (24R)-/(24S)-25-hydroxy-24-methyl-5α-cholestan-3β-yl acetates as well as some related 24-ethyl oxysterol analogs were stereoselectively synthesized directly from the respective parent 24-alkyl sterols by a remote O-insertion reaction with 2,6-dichloropyridine N-oxide (DCP) in the presence of a catalytic amount of (5,10,15,20-tetramesitylporphrinate) ruthenium(II) carbonyl complex [Ru(TMP)CO] and HBr. ¹H- and ¹³C-NMR signals serving to differentiate each of the two epimeric pairs were interpreted. The C-24 alkyl oxysterols epimeric at C-24 were found to be effectively characterized by the aromatic solvent-induced shift (ASIS) by C₅D₅N, particularly for the difference in the ¹³C resonances in the substituted cholestane side chain. A method for differentiating the ¹H and ¹³C signal assignment of the terminal 26-/27-CH₃ in the iso-octane side chain was also discussed on the basis of a combined use of the preferred conformational analysis and HMQC and HMBC techniques. The present method may be useful for determining the stereochemical configuration at C-24 of this type of 24-alkyl oxysterols.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197084     DOI: 10.1007/s11745-012-3739-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

Review 1.  Oxysterols as biomarkers in neurodegenerative diseases.

Authors:  Valerio Leoni; Claudio Caccia
Journal:  Chem Phys Lipids       Date:  2011-04-16       Impact factor: 3.329

Review 2.  Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.

Authors:  Benjamin Wolozin
Journal:  Arch Neurol       Date:  2003-01

Review 3.  Do oxysterols control cholesterol homeostasis?

Authors:  Ingemar Björkhem
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Biomimetic oxidation of unactivated carbons in steroids by a model of cytochrome P-450, oxorutheniumporphyrinate complex.

Authors:  Takashi Lida; Shoujiro Ogawa; Shouhei Miyata; Takaaki Goto; Nariyasu Mano; Junichi Goto; Toshio Nambara
Journal:  Lipids       Date:  2004-09       Impact factor: 1.880

5.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

6.  Oxysterols direct B-cell migration through EBI2.

Authors:  Changlu Liu; Xia V Yang; Jiejun Wu; Chester Kuei; Neelakandha S Mani; Li Zhang; Jingxue Yu; Steven W Sutton; Ning Qin; Homayon Banie; Lars Karlsson; Siquan Sun; Timothy W Lovenberg
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

Review 7.  24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.

Authors:  Cynthia Fourgeux; Alain Bron; Niyazi Acar; Catherine Creuzot-Garcher; Lionel Bretillon
Journal:  Chem Phys Lipids       Date:  2011-04-21       Impact factor: 3.329

8.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain.

Authors:  E G Lund; J M Guileyardo; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  A facile synthesis of C-24 and C-25 oxysterols by in situ generated ethyl(trifluoromethyl)dioxirane.

Authors:  Shoujiro Ogawa; Genta Kakiyama; Akina Muto; Atsuko Hosoda; Kuniko Mitamura; Shigeo Ikegawa; Alan F Hofmann; Takashi Iida
Journal:  Steroids       Date:  2008-10-19       Impact factor: 2.668

10.  Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.

Authors:  K P Kanebratt; U Diczfalusy; T Bäckström; E Sparve; E Bredberg; Y Böttiger; T B Andersson; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  2008-07-23       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.